Rockefeller Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rockefeller Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-72	Closed	-$6K	–	4202
2021 Q4	$6K	Hold	72	–	–	﹤0.01%	3235
2021 Q3	$3K	Hold	72	–	–	﹤0.01%	3383
2021 Q2	$4K	Sell	72 -4,763	-99%	-$310K	﹤0.01%	3129
2021 Q1	$335K	Buy	4,835 +4,285	+779%	+$330K	﹤0.01%	1162
2020 Q4	$42K	Sell	550 -100	-15%	-$7.5K	﹤0.01%	1737
2020 Q3	$48K	Hold	650	–	–	﹤0.01%	1523
2020 Q2	$41K	Buy	650 +500	+333%	+$27.5K	﹤0.01%	1460
2020 Q1	$6K	Hold	150	–	–	﹤0.01%	1925
2019 Q4	$7K	Sell	150 -3,307	-96%	-$156K	﹤0.01%	1722
2019 Q3	$158K	Sell	3,457 -70	-2%	-$3.94K	﹤0.01%	677
2019 Q2	$207K	Buy	+3,527	New	+$182K	﹤0.01%	571

Rockefeller Capital Management's ARNA Position: Q1 2022 in Review

Rockefeller Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 72 shares — an estimated $6K sold.

Rockefeller Capital Management first reported a position in ARNA in Q2 2019 and held it in 11 quarters. The position peaked at $335K in Q1 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Rockefeller Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Rockefeller Capital Management sold 72 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $6K.
Rockefeller Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 11 quarters.
Rockefeller Capital Management's Arena Pharmaceuticals Inc position peaked at $335K in Q1 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Rockefeller Capital Management's 13F filing for Q1 2022, filed 13 May 2022.